4-Methylamphetamine
| 4-MA, 4MA | |
|---|---|
| Salts [] | |
|---|---|
| 4-Methylamphetamine hemisulfate | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 149.23 g/mol [1] |
| Predicted LogP | 2.1 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C10H15N |
| IUPAC name | 1-(4-methylphenyl)propan-2-amine |
| SMILES | CC1=CC=C(C=C1)CC(C)N |
| InChI | InChI=1S/C10H15N/c1-8-3-5-10(6-4-8)7-9(2)11/h3-6,9H,7,11H2,1-2H3 |
| InChIKey | ZDHZDWSHLNBTEB-UHFFFAOYSA-N |
| CAS number | 64-11-9 |
| UNII | 9E273KL7HS |
| PubChem CID | 199116 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 6–12 hours |
| Excretion | Urine |
| Routes of administration | Oral, intranasal, injection |
4-Methylamphetamine (also known as 4-Methyl-amphetamine, p-Methylamphetamine, Aptrol, p-Methylamfetamine, P-tap, Brn 2082438, Pal-313, (+-)-α,4-Dimethylbenzeneethanamine, Benzeneethanamine, α,4-dimethyl-, (+-)- or 4-12-00-02834 (Beilstein Handbook Reference)) is a stimulant substance of the amphetamine class.
Chemistry
Salts []
4-Methylamphetamine is typically found in the form of its hemisulfate salt.
Stereochemistry []
4-Methylamphetamine is a racemic mixture of the enantiomers (optical activity ( + / - )).
| Stereoisomerism |
|---|
| Stereoisomers from PubChem |
Druglikeness
Lipinski's rule of five
4-Methylamphetamine matches Lipinski's rule of five.Subjective effects []
Experience reports
Legal status []
- Canada: 4-Methylamphetamine is a Schedule I.
- United Kingdom: 4-Methylamphetamine is a Class A under the "Misuse of Drugs Act 1971".
- Germany: 4-Methylamphetamine is a Anlage II under the "Betäubungsmittelgesetz (BtMG)".
- United States: 4-Methylamphetamine is a Schedule II (isomer of Methamphetamine) under the "Controlled Substances Act".
See also []
External links []
- 4-Methylamphetamine (Wikipedia)
- 4-Methylamphetamine (PubChem)
- 4-Methylamphetamine (Wikidata)
- 4-Methylamphetamine (ChEMBL)
- 4-Methylamphetamine (Common Chemistry)
- 4-Methylamphetamine (HMDB)
- 4-Methylamphetamine (EPA DSSTox)
- 4-Methylamphetamine (Probes & Drugs)
- 4-Methylamphetamine (Effect Index)
- 4-Methylamphetamine (UNII)
- 4-Methylamphetamine (Erowid)
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 199116, 4-Methylamphetamine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/199116
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. 4-Methylamphetamine. UNII: 9E273KL7HS. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/9E273KL7HS
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 08:01:46 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 08:01:42 |
| erowid | ok | 2026-11-20 08:01:44 |
| gsrs | ok | 2026-11-20 08:01:43 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0246503) | 2026-11-20 08:01:42 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 08:01:48 |
| pubchem | ok | 2026-11-20 08:01:41 |
| ok | 2026-11-20 08:01:42 | |
| sider | missing (not in SIDER) | 2026-11-20 08:01:42 |
| structure | ok | 2026-11-20 08:01:42 |
| wikipedia | ok | 2026-11-20 08:01:43 |